Reporte ASH 2010: ¿La llegada de una nueva era en el tratamiento de primera línea para la LMC?
Como todos los años, alrededor de 30.000 médicos, investigadores y representantes de la industria en todo el mundo se reunieron en los Estados Unidos para debatir acerca de las últimas novedades en leucemias y otras enfermedades hematológicas. Aunque “el ASH” está pensado como un evento donde se reúnen exclusivamente profesionales de la salud, alrededor de 30 representantes de pacientes con LMC, mieloma y linfoma, por ejemplo, asistieron para seguirlo, debatir y difundir las noticias.
"CML Advocates Network" now connects 40 leukaemia patient groups
The "CML Advocates Network", an international platform for patient groups supporting patients and relatives suffering from "Chronic Myeloid Leukaemia" (CML) now connects 40 organisations across all continents. This worldwide network offers support by sharing of best practice, information and advice for CML patient representatives.
Recuerdos de ASH 2009 – por qué volvà a ir…

Now 63 patient organisations from 50 countries are members of the CML Advocates Network

Now 69 patient organisations from 55 countries are members of the CML Advocates Network
The "CML Advocates Network", an international platform for patient groups supporting patients and relatives suffering from "Chronic Myeloid Leukaemia" (CML) now connects 69 organisations from 55 countries across all continents. This worldwide network offers support by sharing of best practice, information and advice for CML patient representatives. We are delighted to welcome our newest member Max Smiles from Thailand! See the list of CML groups in the Network, and our worldwide map.
Now 71 patient organisations from 57 countries are members of the CML Advocates Network
The "CML Advocates Network", an international platform for patient groups supporting patients and relatives suffering from "Chronic Myeloid Leukaemia" (CML) now connects 71 organisations from 57 countries across all continents. This worldwide network offers support by sharing of best practice, information and advice for CML patient representatives. We are delighted to welcome our newest members Korea Blood Cancer Association from South Korea, and The Leukemia, Lymphoma, Myeloma Patients Research and Education Society (LLMBIR) from Turkey! See the list of CML groups in the Network, and our worldwide map.